Study summary
A GLP-1 pill without food rules lowered blood sugar more than oral semaglutide
1.91percentage-point drop in HbA1c with orforglipron 36 mg, vs 1.47 with semaglutide 14 mg
What was tested
Orforglipron, a once-daily small-molecule GLP-1 pill that can be taken without food or water restrictions, against oral semaglutide in type 2 diabetes not controlled on metformin.
What they found
- Over 52 weeks, HbA1c fell 1.91 points with orforglipron 36 mg vs 1.47 with semaglutide 14 mg, from a starting average of 8.3%.
- Both doses of orforglipron beat the matching semaglutide dose.
What it means
A GLP-1 pill that is easier to take could widen access to this drug class.
Last reviewed 2026-11-16 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.